Press ReleaseNicox's Partner Ocumension Therapeutics Receives Priority Review Status for ZERVIATE New Drug Application in China Nicox's partner, Ocumension Therapeutics, announced on April
Press ReleaseNew Data on Two Nicox's Assets, NCX 470 and NCX 1728, Presented at ARVO 2023April 26, 2023 - release at 7:30 am CET Sophia Antipolis, FranceNicox SA (Euronext Paris: FR0013018124, COX), an
Press ReleaseNicox: 2023 Ordinary Shareholder Meeting to be held on June 1st, 2023April 24, 2023 – release at 7:30 am CET Sophia Antipolis, FranceNicox SA.
Press ReleaseNicox Provides First Quarter 2023 Financial and Business Highlights Net revenue of €0.8 million for the first quarter of 2023 Cash position of €21.4 million